Detalhe da pesquisa
1.
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden.
Alzheimers Dement
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38666355
2.
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage.
Alzheimers Dement
; 20(4): 2680-2697, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38380882
3.
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-ß monoclonal antibodies in dominantly inherited Alzheimer's disease.
Eur J Nucl Med Mol Imaging
; 50(9): 2669-2682, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017737
4.
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.
Lancet Neurol
; 23(5): 500-510, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631766
5.
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.
JAMA Neurol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683602
6.
Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease.
Mol Neurodegener
; 18(1): 98, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111006